Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease that frequently requires treatment with high doses of corticosteroids and immunosuppressive drugs. Primary defects in the innate immunity also contribute to an increased susceptibility to infections. Patients with SLE are at an increased risk for infections with several pathogens, among them Mycobacterium tuberculosis, which is a significant cause of morbidity and mortality, especially in endemic regions. TB infection requires awareness for several reasons: first, TB infection thrives under conditions of immunosuppression, may it be secondary to the disease itself or its treatment. Second, shared antigens by mycobacteria and autoantigens have been described, which may be targets for autoantibodies. We present four Brazilian patients, in whom a diagnosis of tuberculosis was determined during or following persistent flares of their disease. The association of SLE and TB is discussed, as well as different aspects of the tuberculosis infection in this selected population, and its possible role in the course of SLE.
Similar content being viewed by others
References
Shoenfeld Y, Isenberg D (1989) The mosaic of autoimmunity. Immunol Today 10:123–126
Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al (2008) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases—2008. Isr Med Assoc J 10:3–7
Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y et al (2008) The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases—2008. Isr Med Assoc J 10:8–12
Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al (2008) The mosaic of autoimmunity: prediction, autoantibodies, and treatment in autoimmune diseases—2008. Isr Med Assoc J 10:13–19
Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Sem Arth Rheum 34:501–537
Fessler BJ (2002) Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 16:281–291
Gaipl US, Munoz LE, Grossmayer G, Lauber K et al (2007) Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmunity 28:114–121
Lang KS, Burow A, Kurrer M, Lang PA, Recher M (2007) The role of the innate immune response in autoimmune disease. J Autoimmunity 29:206–212
Zandman-Goddard G, Shoenfeld Y (2003) SLE and infections. Clin Rev All Immunol 25:29–39
Woon-Leung NG (2006) Infections in patients with systemic lupus erythematosus. APLAR J Rheumatol. 9:89–97
Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475–82
Hill HM, Kirshbaum JD (1956) Military tuberculosis developing during prolonged cortisone therapy of systemic lupus erythematosus. Ann Intern Med 44:781–790
Balakrishnan C, Mangat G, Mittal G, Joshi VR (1998) Tuberculosis in patients with systemic lupus erythematosus. J Assoc Physicians India 46:682–683
Sayarlioglu M, Inanc M, Kamali S et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13:274–278
Vitorio-Navarra STG, Dy EER, Arroyo CG et al (1996) Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 26:628–634
Erdozain J-G, Ruiz-Irastorza G, Egurbide M-V et al (2006) High risk of tuberculosis in systemic lupus erythematosus? Lupus 15:232–235
Tam LS, Li EK, Wong SM, Szeto CC (2002) Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong-Kong. Scand J Rheumatol 31:296–300
Hou CL, Tsai YC, Chen LC et al (2008) Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared. Clin Rheumatol 27:557–563
Hernández-Cruz B, Sifuentes-Osornio J, Ponce-de-León Rosales S, Ponce-de-León Garduño A, Díaz-Jouanen E (1999) Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series. Clin Exp Rheumatol 17:289–296
Mok MY, Lo Y, Chan TM, Wong WS, Lau CS (2005) Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. J Rheumatol 32:609–615
Yun JE, Lee SW, Kim TH, Jun JB, Jung S, Bae SC, Kim TY, Yoo DH (2002) The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132
Feng PH, Tan TH (1982) Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 41(1):11–14
Sousa DC, Medeiros MMC (2008) Lúpus eritematoso sistêmico e tuberculose renal: descrição de nove casos. Rev Bras Reumatol. 48:2–6
Favalli EG, Desiati F, Atzeni F, Sarzi-Puttini P, Caporali R, Pallavicini FB et al (2009) Serious infections during anti-TNFalpha treatment in rheumatoid arthritis. Autoimmun Rev 8:266–273
Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N et al (2008) Infections as triggers and complications of systemic lúpus erythematosus. Autoimmun Rev 8:24–28
Lalvani A, Millington KA (2008) Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun Rev 8:147–152
Sela O, El-Roeiy A, Pick AI, Shoenfeld Y (1987) Immunoglobulin levels in Klebsiella and TB infection. Immunol Lett 15:117–220
Shoenfeld Y, Isenberg DA (1988) Mycobacteria and autoimmunity. Immunology Today 9:178–181
Purice S, Mitu S, Popescu T et al (1982) The relationship between systemic lupus erythematosus and tuberculosis. Med Intern 20:191–196
Shoenfeld Y, Vilner Y, Coates AR et al (1986) Monoclonal anti-tuberculosis antibodies react with DNA and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255–261
Amital-Teplizic H, Avinoach I, Coates AR et al (1989) Binding of monoclonal anti-DNA and anti-TB glycolipids to brain tissue. Autoimmunity 4:277–287
Sela O, El-Roeiy A, Isenberg DA, Kennedy RC, Colaco CB, Pinkhas J, Shoenfeld Y (1987) A common anti-DNA antibody idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 30:50–55
Isenberg DA, Maddison P, Swana G, Jones M, Dudeney C, El-Roeiy A, Shoenfeld Y (1987) Profile of autoantibodies in the sera of patients with tuberculosis, Klebsiella and other gram-negative infections. Clin Exp Immunol 67:516–523
Teplizki H, Buskila D, Isenberg DA, Coates ARM, Sukenik S, Horowitz J, Shoenfeld Y (1987) Low serum anti-TB glycolipid antibodies titer in the sera of patients with SLE as an indicator of CNS involvement. J Rheumatol 14:507
Amital-Teplizki H, Avinoach I, Coates ARM, Kooperman O, Blank M, Shoenfeld Y (1989) Binding of monoclonal anti-DNA and anti-TB glycolipid to brain tissue. Autoimmunity 4:277–287
Blank M, Mendlovic S, Mozes E, Coates ARM, Shoenfeld Y (1991) Induction of SLE in naive mice with T cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculous antibody (TB/68) antibody (16/6 Id+). Clin Immunol Immunopathol 60:471–483
Harats D, Yacov N, Gilburd B, Shoenfeld Y, George J (2002) Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Col Cardiol 7:1333–1338
Mandal K, Jahangiri M, Xu Q (2004) Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun Rev 3:31–37
Quintana FJ, Cohen IR (2005) DNA vaccines coding for heat-shock proteins (HSP): tools for the activation of HSP-specific regulatory T cells. Expert Opin Biol Ther 5:545–554
Alard JE, Dueymes M, Youinou P, Jamim C (2007) Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun Rev 6:438–443
Tishler M, Shoenfeld Y (1996) Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases. Semin Arthritis Rheum 26:558–563
Adams JS, Hewison M (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4:80–90
Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66:1137–42
Nnoaham KE, Clarke A (2008) Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 37:113–9
Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 1109:385–400
Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y (2007) Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci 1109:550–557
Papadimitraki ED, Bertsias GK, Boumpas DT (2007) Toll like receptors and autoimmunity: a critical appraisal. J Autoimmunity 29:310–318
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ribeiro, F.M., Szyper-Kravitz, M., Klumb, E.M. et al. Can Lupus Flares be Associated with Tuberculosis Infection?. Clinic Rev Allerg Immunol 38, 163–168 (2010). https://doi.org/10.1007/s12016-009-8149-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-009-8149-7